Cross-sectional association of serum phosphate with carotid intima-medial thickness in hemodialysis patients

被引:67
作者
Ishimura, E
Taniwaki, H
Tabata, T
Tsujimoto, Y
Jono, S
Emoto, M
Shoji, T
Inaba, M
Inoue, T
Nishizawa, Y
机构
[1] Osaka City Univ, Grad Sch Med, Dept Nephrol, Abeno Ku, Osaka 5458585, Japan
[2] Osaka City Univ, Grad Sch Med, Dept Endocrinol Metab & Mol Med, Osaka 5458585, Japan
[3] Inoue Hosp, Suita, Osaka, Japan
关键词
intima-medial thickness (IMT); hemodialysis (HD); phosphate; diabetes;
D O I
10.1053/j.ajkd.2005.02.008
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Although an increased serum phosphate concentration is a significant risk factor for vascular calcification, it is unclear whether serum phosphate level is a risk factor for increased arterial wall thickness in hemodialysis patients. Methods: Using B-mode ultrasonography, we examined intima-medial thickness (IMT) of the carotid artery of hemodialysis patients and analyzed risk factors for increased IMT with regard to the effect of serum phosphate. Seven hundred sixteen hemodialysis patients were enrolled (547 patients without diabetes, 169 patients with diabetes; 441 men, 275 women; age, 60 +/- 8.5 years). Results IMT of patients with diabetes was significantly greater than that of patients without diabetes (0.859 +/- 0.250 versus 0.783 +/- 0.178 mm;P < 0.0001). For the group of all patients, IMT correlated weakly, but significantly, with serum phosphate level (r = 0.093; P = 0.0127). In multiple regression analysis of the group of all patients, greater serum phosphate level (0 = 0.166; P < 0.0001) was shown to be a significant independent risk factor for Increased carotid IMT, in addition to other significant independent risk factors, including advanced age, higher blood pressure, greater non-high-density lipoprotein cholesterol level, and the presence of diabetes (R-2 = 0.1119; P < 0.00001). In multiple regression analyses performed separately for hemodialysis patients without and with diabetes, greater phosphate level and advanced age were significant independent risk factors for Increased IMT, independent of other confounding risk factors. Conclusion: These results show that in addition to advanced age, greater serum phosphate level is a significant and independent factor associated with advanced arteriosclerosis in hemodialysis patients with and without diabetes, suggesting that phosphate levels should be controlled appropriately to prevent an increase in arterial wall thickness In hemodialysis patients.
引用
收藏
页码:859 / 865
页数:7
相关论文
共 29 条
[1]   Lanthanum carbonate: a new phosphate binder [J].
Behets, GJ ;
Verberckmoes, SC ;
D'Haese, PC ;
De Broe, ME .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2004, 13 (04) :403-409
[2]   Common carotid intima-media thickness and risk of stroke and myocardial infarction - The Rotterdam Study [J].
Bots, ML ;
Hoes, AW ;
Koudstaal, PJ ;
Hofman, A ;
Grobbee, DE .
CIRCULATION, 1997, 96 (05) :1432-1437
[3]   ARTERIAL-WALL THICKNESS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR-DISEASE IN MIDDLE-AGED ADULTS - THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY [J].
BURKE, GL ;
EVANS, GW ;
RILEY, WA ;
SHARRETT, AR ;
HOWARD, G ;
BARNES, RW ;
ROSAMOND, W ;
CROW, RS ;
RAUTAHARJU, PM ;
HEISS, G .
STROKE, 1995, 26 (03) :386-391
[4]   Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients [J].
Chertow, GM ;
Burke, SK ;
Raggi, P .
KIDNEY INTERNATIONAL, 2002, 62 (01) :245-252
[5]   Evidence for increased cardiovascular disease risk in patients with chronic kidney disease [J].
Coresh, J ;
Astor, B ;
Sarnak, MJ .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2004, 13 (01) :73-81
[6]   Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia [J].
Cozzolino, M ;
Staniforth, ME ;
Liapis, H ;
Finch, J ;
Burke, SK ;
Dusso, AS ;
Slatopolsky, E .
KIDNEY INTERNATIONAL, 2003, 64 (05) :1653-1661
[7]  
Cozzolino M, 2001, J AM SOC NEPHROL, V12, P2511, DOI 10.1681/ASN.V12112511
[8]   Pathophysiological mechanisms of vascular calcification in end-stage renal disease [J].
Davies, MR ;
Hruska, KA .
KIDNEY INTERNATIONAL, 2001, 60 (02) :472-479
[9]   Clinical epidemiology of cardiovascular disease in chronic renal disease [J].
Foley, RN ;
Parfrey, PS ;
Sarnak, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S112-S119
[10]   Vascular calcification and inorganic phosphate [J].
Giachelli, CM ;
Jono, S ;
Shioi, A ;
Nishizawa, Y ;
Mori, K ;
Morii, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) :S34-S37